British Journal of Cancer - Table of Contents alert Volume 116 Issue 6

If you are unable to see the message below, click here to view.

Advertisement All content now free to access including archives! Nature Communications is an open access journal that publishes high-quality research from all areas of the natural sciences. Papers published by the journal represent important advances of significance to specialists within each subject area including the life sciences. Visit the website to explore ALL the content available within your field >> TABLE OF CONTENTS Volume 116, Issue 6 (697-840) Published online 14 March 2017 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Epidemiology Corrigenda Also new today Advance online publication Digital Edition Follow us on Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Clinical Studies Top Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer Talia Golan, Tal Sella, Eileen M O'Reilly, Matthew H G Katz, Ron Epelbaum, David P Kelsen, Ayelet Borgida, Hannah Maynard, Hedy Kindler, Eitan Friedmen, Milind Javle and Steven Gallinger Br J Cancer 2017 116: 697-702; advance online publication, February 9, 2017; 10.1038/bjc.2017.19 Abstract | Full Text Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma Sanjeevan Muruganandan, Helman Alfonso, Peter Franklin, Keith Shilkin, Amanda Segal, Nola Olsen, Alison Reid, Nick de Klerk, AW (Bill) Musk and Fraser Brims Br J Cancer 2017 116: 703-708; advance online publication, February 14, 2017; 10.1038/bjc.2017.20 Abstract | Full Text Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer T Crosby, C N Hurt, S Falk, S Gollins, J Staffurth, R Ray, J A Bridgewater, J I Geh, D Cunningham, J Blazeby, R Roy, T Maughan, G Griffiths and S Mukherjee Br J Cancer 2017 116: 709-716; advance online publication, February 14, 2017; 10.1038/bjc.2017.21 Abstract | Full Text Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer Sandi L Pruitt, Andrew L Laccetti, Lei Xuan, Ethan A Halm and David E Gerber Br J Cancer 2017 116: 717-725; advance online publication, February 14, 2017; 10.1038/bjc.2017.27 Abstract | Full Text Translational Therapeutics Top Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2− advanced breast cancer: results from BOLERO-2 Mary Ellen Moynahan, David Chen, Wei He, Patricia Sung, Aliaksandra Samoila, Daoqi You, Trusha Bhatt, Parul Patel, Francois Ringeisen, Gabriel N Hortobagyi, Jose Baselga and Sarat Chandarlapaty Br J Cancer 2017 116: 726-730; advance online publication, February 9, 2017; 10.1038/bjc.2017.25 Abstract | Full Text Prognostication and monitoring of mesothelioma using biomarkers: a systematic review David T Arnold, Duneesha De Fonseka, Fergus W Hamilton, Najib M Rahman and Nick A Maskell Br J Cancer 2017 116: 731-741; advance online publication, February 7, 2017; 10.1038/bjc.2017.22 Abstract | Full Text MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib Cassandre Yip, Pierre Foidart, Joan Somja, Alice Truong, Mehdi Lienard, Emilie Feyereisen, Hélène Schroeder, Stéphanie Gofflot, Anne-Françoise Donneau, Joëlle Collignon, Philippe Delvenne, Nor Eddine Sounni, Guy Jerusalem and Agnès Noël Br J Cancer 2017 116: 742-751; advance online publication, February 14, 2017; 10.1038/bjc.2017.23 Abstract | Full Text Molecular Diagnostics Top High folic acid diet enhances tumour growth in PyMT-induced breast cancer Mariann Fagernæs Hansen, Sarah Østrup Jensen, Ernst-Martin Füchtbauer and Pia M Martensen Br J Cancer 2017 116: 752-761; advance online publication, February 2, 2017; 10.1038/bjc.2017.11 Abstract | Full Text Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis Jane V Carter, Norman J Galbraith, Dongyan Yang, James F Burton, Samuel P Walker and Susan Galandiuk Br J Cancer 2017 116: 762-774; advance online publication, February 2, 2017; 10.1038/bjc.2017.12 Abstract | Full Text Asporin is a stromally expressed marker associated with prostate cancer progression Annie Rochette, Nadia Boufaied, Eleonora Scarlata, Lucie Hamel, Fadi Brimo, Hayley C Whitaker, Antonio Ramos-Montoya, David E Neal, Alice Dragomir, Armen Aprikian, Simone Chevalier and Axel A Thomson Br J Cancer 2017 116: 775-784; advance online publication, February 2, 2017; 10.1038/bjc.2017.15 Abstract | Full Text Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature Artem Kaznatcheev, Robert Vander Velde, Jacob G Scott and David Basanta Br J Cancer 2017 116: 785-792; advance online publication, February 9, 2017; 10.1038/bjc.2017.5 Abstract | Full Text Genetics & Genomics Top Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis Daniela Furlan, Davide Trapani, Enrico Berrino, Carla Debernardi, Mara Panero, Laura Libera, Nora Sahnane, Cristina Riva, Maria Grazia Tibiletti, Fausto Sessa, Anna Sapino and Tiziana Venesio Br J Cancer 2017 116: 793-801; advance online publication, January 31, 2017; 10.1038/bjc.2017.9 Abstract | Full Text Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients Umberto Malapelle, Clara Mayo de-Las-Casas, Danilo Rocco, Monica Garzon, Pasquale Pisapia, Nuria Jordana-Ariza, Maria Russo, Roberta Sgariglia, Caterina De Luca, Francesco Pepe, Alejandro Martinez-Bueno, Daniela Morales-Espinosa, María González-Cao, Niki Karachaliou, Santiago Viteri Ramirez, Claudio Bellevicine, Miguel Angel Molina-Vila, Rafael Rosell and Giancarlo Troncone Br J Cancer 2017 116: 802-810; advance online publication, February 7, 2017; 10.1038/bjc.2017.8 Abstract | Full Text Epidemiology Top Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort Esther Molina-Montes, María-José Sánchez, Genevieve Buckland, H B(as) Bueno-de-Mesquita, Elisabete Weiderpass, Pilar Amiano, Petra A Wark, Tilman Kühn, Verena Katzke, José María Huerta, Eva Ardanaz, José Ramón Quirós, Aurélie Affret, Mathilde His, Marie-Christine Boutron-Ruault, Petra H Peeters, Weimin Ye, Malin Sund, Heiner Boeing, Khalid Iqbal, Bodil Ohlsson, Emily Sonestedt, Anne Tjønneland, Kristina EN Petersen, Ruth C Travis, Guri Skeie, Claudia Agnoli, Salvatore Panico, Domenico Palli, Rosario Tumino, Carlotta Sacerdote, Heinz Freisling, Inge Huybrechts, Kim Overvad, Antonia Trichopoulou, Christina Bamia, Effie Vasilopoulou, Nick Wareham, Kay-Tee Khaw, Amanda J Cross, Heather A Ward, Elio Riboli and Eric J Duell Br J Cancer 2017 116: 811-820; advance online publication, February 7, 2017; 10.1038/bjc.2017.14 Abstract | Full Text Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications S De Placido, C De Angelis, M Giuliano, C Pizzi, R Ruocco, V Perrone, D Bruzzese, G Tommasielli, M De Laurentiis, S Cammarota, G Arpino and G Arpino Br J Cancer 2017 116: 821-827; advance online publication, February 7, 2017; 10.1038/bjc.2017.24 Abstract | Full Text Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011 Stephen Morrell, Richard Taylor, David Roder, Bridget Robson, Marli Gregory and Kirsty Craig Br J Cancer 2017 116: 828-839; advance online publication, February 9, 2017; 10.1038/bjc.2017.6 Abstract | Full Text Corrigenda Top Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data Alex J Walker, David R Baldwin, Tim R Card, Helen A Powell, Richard B Hubbard and Matthew J Grainge Br J Cancer 2017 116: e1; advance online publication, November 1, 2016; 10.1038/bjc.2016.364 Full Text High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers M Miyamoto, M Takano, K Iwaya, N Shinomiya, T Goto, M Kato, A Suzuki, T Aoyama, J Hitrata, I Nagaoka, H Tsuda and K Furuya Br J Cancer 2017 116: e2; advance online publication, November 10, 2016; 10.1038/bjc.2016.371 Full Text Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis N M A White, O Masui, D Newsted, A Scorilas, A D Romaschin, G A Bjarnason, K W M Siu and G M Yousef Br J Cancer 2017 116: e3; advance online publication, January 12, 2017; 10.1038/bjc.2016.441 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.